Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1
about
Few and far between: how HIV may be evading antibody avidityAntibody vs. HIV in a clash of evolutionary titansComprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesPolyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsNeutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitorsAntigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cellsHIV and the chemokine system: 10 years later.Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesStructural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design ImplicationsStructure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivityCross-neutralization of influenza A viruses mediated by a single antibody loopDiverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 bindingHeavy Chain-Only IgG2b Llama Antibody Effects Near-Pan HIV-1 Neutralization by Recognizing a CD4-Induced Epitope That Includes Elements of Coreceptor- and CD4-Binding SitesRecent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal AntibodiesHIV-1 gp120 as a therapeutic target: navigating a moving labyrinthA novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environmentStabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoproteinA Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 UpregulationElicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoproteinAnti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypesComplement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infectionMapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular EntrySoluble Envelope Glycoprotein Trimers from a CD4-Independent HIV-1 Elicit Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Guinea PigsPassive immunization against HIV/AIDS by antibody gene transfer.Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins.Real-time Recognition of Mycobacterium tuberculosis and Lipoarabinomannan using the Quartz Crystal Microbalance.3D visualization of HIV transfer at the virological synapse between dendritic cells and T cellsNeutralization sensitivity of HIV-1 subtype B' clinical isolates from former plasma donors in China.Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.Identification of the HIV-1 gp41 core-binding motif--HXXNPF.Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage.An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10sCD4-17b bifunctional protein: extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates.B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers.Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library.A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitorsAffinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41
P2860
Q21090507-87460A3D-CAF0-47B7-8F31-F62F09C2B8CBQ24536059-F6BD8548-0BD2-487A-80F6-9FF32D66C8D6Q24561905-611883E5-DEE2-4D3C-8CA1-7A430DE8C96DQ24635002-3DCC2EBC-2778-4CA7-AD97-75EB2F514C0EQ24655129-82401623-C002-4915-92BD-ED7826A3B3D4Q27320687-7E22FDEE-0729-4188-8AFB-1641FB800E69Q27473020-0EC8BAE2-7692-4DCD-9C82-4D329B3481EDQ27489000-9890B325-38DF-42E1-AE6C-0AB5F3926BF8Q27643185-A9928466-F189-488A-8F3E-2FDA7E427BDBQ27657377-4E503269-E9DB-4642-9491-A68879F83C8CQ27660384-9C46CE0B-B30F-4D39-A8CC-C8958F47E53BQ27673206-D78A3845-4C33-4833-88F0-A554A8CDCF48Q27675486-E91C562D-9E50-44F0-983B-9144A370C7D3Q27679031-0C5E808A-6CEB-410E-B170-54609675654BQ28068946-788D5669-2D47-4372-8260-9865F737BE0AQ28086826-73863ABB-B6E8-4BEF-935F-9EDD56C53A8AQ28476693-8C7B17E5-2679-487C-BCD2-28226F9A577EQ28534454-AACF48B1-8F16-4691-931C-6EABC0FBA172Q28553032-F4B6247F-55CB-4585-B275-87465721DC05Q28732438-2157C6FD-9606-442E-A2A6-873FCA302298Q28752503-A9790D65-1E17-4C47-A485-C9BF969D87FDQ28766705-417579A9-224C-41AA-AC6C-CA635EF57B01Q30276615-837F30BF-C1A6-4A60-B053-147B154F2741Q30278897-9622B369-9F5D-431B-B031-D5B3F61C1D4BQ30358434-861B88B2-8119-4F96-B358-EA4618E2834AQ30358769-449B3C7B-31B2-4270-B62F-D92551670547Q30447858-D857F67E-194E-45B8-847D-915E44377A17Q30496061-D13BA535-B181-446C-AAD9-99E3D5694056Q30537665-21B89A77-CA34-4787-95A6-5970DF837CF1Q30843874-DBD50FFC-2BF6-459E-A5C9-703FE0511CBCQ33205911-CDBBD7D7-128B-4DA1-BA15-E8173C55A71FQ33253687-3F7924E9-0B58-42C0-901C-19C5CDA986AAQ33269999-CC377CC7-2E82-478F-9753-5066E6D8C18CQ33272711-3CFEFCA8-B261-45C7-A65C-BCEF470EDD0CQ33348658-3CAF6786-089D-4D00-978E-8B0F3D9AA4CBQ33373664-77739B2A-15B2-4D02-8774-E1D442E0252DQ33380012-C6DBA277-78D7-46F3-AD8D-11777061279CQ33431668-DB910CB8-BF26-42E8-9549-B781EBC065DCQ33483840-3F4B19D8-4463-45D2-912B-923E7EA82EE8Q33523258-511CC5DC-4D03-476C-B2A3-F280C6196BFA
P2860
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Access of antibody molecules t ...... immunodeficiency virus type 1
@ast
Access of antibody molecules t ...... immunodeficiency virus type 1
@en
Access of antibody molecules t ...... immunodeficiency virus type 1
@nl
type
label
Access of antibody molecules t ...... immunodeficiency virus type 1
@ast
Access of antibody molecules t ...... immunodeficiency virus type 1
@en
Access of antibody molecules t ...... immunodeficiency virus type 1
@nl
prefLabel
Access of antibody molecules t ...... immunodeficiency virus type 1
@ast
Access of antibody molecules t ...... immunodeficiency virus type 1
@en
Access of antibody molecules t ...... immunodeficiency virus type 1
@nl
P2093
P2860
P50
P3181
P1433
P1476
Access of antibody molecules t ...... immunodeficiency virus type 1
@en
P2093
Aarti Raja
Aran F Labrijn
Chih-Chin Huang
Christoph Grundner
Dennis R Burton
Dimiter S Dimitrov
James Binley
James Robinson
Karla Delgado
Michael B Zwick
P2860
P304
P3181
P356
10.1128/JVI.77.19.10557-10565.2003
P407
P577
2003-10-01T00:00:00Z